Prelude Therapeutics to Present Breast Cancer Drug Data at AACR 2026
WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) will present preclinical data on its experimental breast cancer drug candidate at the American Association for Cancer Research Annual Meeting 2026, the …
Prelude Therapeutics to Present Breast Cancer Drug Data at AACR 2026 Read More